Aveanna Healthcare Holdings (AVAH) has put fresh earnings in focus after reporting first quarter results, with higher sales and net income than a year earlier and slightly raised full year revenue guidance.

At a share price of US$7.33, Aveanna has pulled back about 4% over the past week but is still up roughly 12% over 30 days. Its 1 year total shareholder return of about 38% and very large 3 year total shareholder return suggest earlier buyers have already seen substantial gains, indicating momentum has cooled recently even as interest over the longer term has been strong.

If this earnings story has you looking beyond a single stock, it could be a good moment to see what else is moving in healthcare technology, including 34 healthcare AI stocks.

With stronger recent earnings, a raised full year revenue range and the stock trading below some valuation estimates, it is worth asking whether Aveanna is still underappreciated or if the market is already pricing in future growth.

Most Popular Narrative: 26.3% Undervalued

With the widely followed narrative pointing to a fair value of $9.95 against Aveanna's last close at $7.33, the key question is how those long range cash flow and earnings assumptions stack up.

Accelerating adoption of home based healthcare and increasing patient preference for in home care are associated with strong and sustained demand for Aveanna's services. Management has repeatedly noted that this demand remains robust and exceeds the company's current capacity, which supports the potential for additional future revenue as the company hires and retains more caregivers.

Want to see what is behind that growth story? The narrative focuses on steady revenue expansion, shifting profit margins and a richer earnings multiple that assumes investors will pay more for this profile.

Result: Fair Value of $9.95 (UNDERVALUED)

However, you also need to weigh Aveanna's reliance on Medicaid and Medicare reimbursement, as well as its US$1.47b variable rate debt, which both introduce meaningful execution risk.

Next Steps

With sentiment split between concern about risks and interest in potential rewards, this is a good moment to review the data yourself and act on your own judgment using 3 key rewards and 2 important warning signs

Looking for more investment ideas?

If you stop with just one stock, you risk missing other opportunities that fit your goals, time horizon and comfort with risk.

• Target potential mispricings by scanning 48 high quality undervalued stocks that combine quality fundamentals with room for a re-rating.
• Strengthen your income focus by reviewing 10 dividend fortresses that aim to pair higher yields with resilient cash flows.
• Dial down risk by checking 69 resilient stocks with low risk scores built around sturdier balance sheets and more predictable business profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.